INTERSECTION OF MULTIPLE BIRTHS, BIRTH TRAUMA AND PERINATAL MENTAL HEALTH Connecting multiple birth parents with a diverse range of organisations that provide support
With
Danya McStein,
Clinical Team Manager
Gidget Foundation Australia
Maddison Granger,
Gidget Angel (patient)
SEGMENT
Filmed in Sydney & Tahmoor, NSW | March 2026
Aussie mum Maddi was suddenly thrust into motherhood when her twin girls arrived nine weeks early. Immediately after their traumatic birth, she was rushed into the operating theatre for emergency care. Like many families of multiples, her newborns were taken straight to the NICU, where they remained for two months.
Despite the intensity of her experience – the traumatic delivery, the post‑operative complications and the daily 3‑hour round trips to sit beside her babies in the NICU – not a single healthcare professional checked in on Maddi’s mental wellbeing.
Maddi’s story reflects a broader, often overlooked gap in perinatal care for parents of multiples. Mothers of multiples are five times more likely to experience depression and have triple the rates of anxiety compared to mothers of singletons
Danya McStein is a Clinical Team Manager at Gidget Foundation Australia. She has experience as a psychologist, board-approved supervisor and educator, with a background across clinical practice, wellbeing consulting, university teaching and training facilitation.
Danya spoke with Australian Health Journal about mothers expecting twins showing prenatal depressive symptoms, while postpartum, facing higher risks of clinical exhaustion and postpartum depression.
Australian Health Journal spoke with Maddison (“Maddi”) Granger, the mother of twin girls who experienced perinatal mental health issues following the traumatic birthing experience and a terrifying post-birth operating emergency. She lives in Tahmoor, a town in Wollondilly Shire of the Macarthur Region in NSW, and is a Gidget Angel, with Gidget Foundation Australia.
Source: Supplied and adapted
You Might also like
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
-
Psychiatrists to discuss connectedness at RANZCP 2023 Congress
Next week, at the Perth Convention and Exhibition Centre, The Royal Australian and New Zealand College of Psychiatrists (RANZCP) meet for the RANZCP 2023 Congress on the theme of “New Horizons: Connected Futures”
Australian Health Journal spoke to current President-Elect Dr Elizabeth Moore and soon to be President, RANZCP about the Congress, as well as the recent Federal Budget announcements around mental health funding.